What Lonza's $1.2B Buy of Roche Biologics Plant Means for CDMO Market : vimarsana.com

The Swiss contract manufacturer’s cash deal for Roche’s Genentech facility in Vacaville, California, is one of the world’s largest manufacturing sites for biologics—a major growth driver for Lonza and other CDMOs.

Related Keywords

California , United States , Spain , Switzerland , Singapore , Visp , Switzerland General , New Hampshire , Swiss , Jean Christophe Hyvert , Gil Roth , William Blair , Lonza Vacaville , Straits Research , Pharma Biopharma Outsourcing Association , Genentech , Christophe Hyvert , West Coast , East Coast , Nova One Advisor , Charles River , Max Smock , Biopharma Outsourcing Association , Resume , Areers , Hat Lonzas 1 2b Buy Of Roche Biologics Plant Means For Cdmo Market , Iospace , Dvice ,